Inactivated adjuvanted Influenza Vaccine — Competitive Intelligence Brief

Inactivated adjuvanted Influenza Vaccine (Inactivated adjuvanted Influenza Vaccine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vaccine. Area: Immunology.

phase 3 Vaccine Immunology Biologic

Target snapshot

Inactivated adjuvanted Influenza Vaccine (Inactivated adjuvanted Influenza Vaccine) — Sanofi Pasteur, a Sanofi Company. This vaccine stimulates the immune system to recognize and respond to influenza virus antigens, with an adjuvant to enhance the immune response.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Inactivated adjuvanted Influenza Vaccine TARGET	Inactivated adjuvanted Influenza Vaccine	Sanofi Pasteur, a Sanofi Company	phase 3	Vaccine
Comirnaty	BNT162b2 (tozinameran)	Pfizer Inc.	marketed	vaccine	SARS-CoV-2 virus	2021-08-23
Prevnar 20	pneumococcal 20-valent conjugate vaccine (PCV20)	Pfizer Inc.	marketed	Pneumococcal conjugate vaccine	Streptococcus pneumoniae capsular polysaccharides (20 serotypes)	2021-06-08
IXIARO®- Japanese Encephalitis vaccine	IXIARO®- Japanese Encephalitis vaccine	Medical University of Vienna	marketed	Inactivated viral vaccine
MenACWY-CRM (Menveo)	MenACWY-CRM (Menveo)	GlaxoSmithKline	marketed	Conjugate vaccine
BNT162b2 (Omi XBB.1.5)/RIV	bnt162b2-omi-xbb-1-5-riv	Pfizer	marketed	vaccine	SARS-CoV-2
High Dose Trivalent Influenza Vaccine	High Dose Trivalent Influenza Vaccine	Brigham and Women's Hospital	marketed	Inactivated influenza vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

• 2033-06-01 — Prevnar 20 · US 8,895,024 · Composition of matter · US
• 2035-06-01 — Prevnar 20 · US 10,279,033 · Method of use · US

Sponsor landscape (Vaccine class)

1. GlaxoSmithKline · 16 drugs in this class
2. Sanofi Pasteur, a Sanofi Company · 12 drugs in this class
3. Pfizer · 6 drugs in this class
4. International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
5. Henogen · 3 drugs in this class
6. Pfizer Inc. · 2 drugs in this class
7. Sanofi · 2 drugs in this class
8. Jiangsu Province Centers for Disease Control and Prevention · 2 drugs in this class
9. BioNTech · 2 drugs in this class
10. Merck Sharp & Dohme LLC · 2 drugs in this class